BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21840566)

  • 41. Lack of interleukin-10 expression could predict poor outcome in patients with stage I non-small cell lung cancer.
    Soria JC; Moon C; Kemp BL; Liu DD; Feng L; Tang X; Chang YS; Mao L; Khuri FR
    Clin Cancer Res; 2003 May; 9(5):1785-91. PubMed ID: 12738735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
    Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
    Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell lung cancer.
    Bennett WP; el-Deiry WS; Rush WL; Guinee DG; Freedman AN; Caporaso NE; Welsh JA; Jones RT; Borkowski A; Travis WD; Fleming MV; Trastek V; Pairolero PC; Tazelaar HD; Midthun D; Jett JR; Liotta LA; Harris CC
    Clin Cancer Res; 1998 Jun; 4(6):1499-506. PubMed ID: 9626468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer.
    Graziano SL; Tatum AH; Gonchoroff NJ; Newman NB; Kohman LJ
    Clin Cancer Res; 1997 Jan; 3(1):87-93. PubMed ID: 9815542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
    Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
    Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclin A and Cyclin E expression in resected non-small cell lung cancer stage I-IIIA.
    Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Dyla T; Jankowska R
    In Vivo; 2009; 23(4):519-25. PubMed ID: 19567385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prognostic impact of NF-kappaB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer.
    Al-Saad S; Al-Shibli K; Donnem T; Persson M; Bremnes RM; Busund LT
    Br J Cancer; 2008 Nov; 99(9):1476-83. PubMed ID: 18854838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic evaluation of CapG, gelsolin, P-gp, GSTP1, and Topo-II proteins in non-small cell lung cancer.
    Zhu WY; Hunag YY; Liu XG; He JY; Chen DD; Zeng F; Zhou JH; Zhang YK
    Anat Rec (Hoboken); 2012 Feb; 295(2):208-14. PubMed ID: 22190510
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic implications of human leukocyte antigen class I expression in patients who underwent surgical resection for non-small-cell lung cancer.
    Hanagiri T; Shigematsu Y; Kuroda K; Baba T; Shiota H; Ichiki Y; Nagata Y; Yasuda M; Uramoto H; So T; Takenoyama M; Tanaka F
    J Surg Res; 2013 May; 181(2):e57-63. PubMed ID: 22878150
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer.
    Ohgino K; Soejima K; Yasuda H; Hayashi Y; Hamamoto J; Naoki K; Arai D; Ishioka K; Sato T; Terai H; Ikemura S; Yoda S; Tani T; Kuroda A; Betsuyaku T
    Lung Cancer; 2014 Jan; 83(1):90-6. PubMed ID: 24239165
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene profiling of clinical routine biopsies and prediction of survival in non-small cell lung cancer.
    Baty F; Facompré M; Kaiser S; Schumacher M; Pless M; Bubendorf L; Savic S; Marrer E; Budach W; Buess M; Kehren J; Tamm M; Brutsche MH
    Am J Respir Crit Care Med; 2010 Jan; 181(2):181-8. PubMed ID: 19833826
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stromal CD4/CD25 positive T-cells are a strong and independent prognostic factor in non-small cell lung cancer patients, especially with adenocarcinomas.
    Kayser G; Schulte-Uentrop L; Sienel W; Werner M; Fisch P; Passlick B; Zur Hausen A; Stremmel C
    Lung Cancer; 2012 Jun; 76(3):445-51. PubMed ID: 22300751
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy.
    Hald SM; Bremnes RM; Al-Shibli K; Al-Saad S; Andersen S; Stenvold H; Busund LT; Donnem T
    Lung Cancer; 2013 May; 80(2):209-15. PubMed ID: 23384671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reactive oxygen species modulator 1 (Romo1) overexpression is an independent predictor of poor survival in NSCLC patients who undergo surgical resection.
    Lee SH; Min JW; Lee JS; Kim CH; Yoo YD; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
    Lung Cancer; 2015 Jan; 87(1):45-52. PubMed ID: 25468147
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic role of clusterin in resected adenocarcinomas of the lung.
    Panico F; Casali C; Rossi G; Rizzi F; Morandi U; Bettuzzi S; Davalli P; Corbetta L; Storelli ES; Corti A; Fabbri LM; Astancolle S; Luppi F
    Lung Cancer; 2013 Mar; 79(3):294-9. PubMed ID: 23276503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TKTL-1 expression in lung cancer.
    Fritz P; Coy JF; Mürdter TE; Ott G; Alscher MD; Friedel G
    Pathol Res Pract; 2012 Apr; 208(4):203-9. PubMed ID: 22445516
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of p53 and EGFR as prognostic biomarkers in stage I non-small cell lung cancer.
    Donahue JM
    J Surg Oncol; 2014 Aug; 110(2):97-8. PubMed ID: 24895315
    [No Abstract]   [Full Text] [Related]  

  • 59. Psf3 is a prognostic biomarker in lung adenocarcinoma.
    Hokka D; Maniwa Y; Tane S; Nishio W; Yoshimura M; Okita Y; Ohbayashi C; Sakai Y; Chen X; Hayashi Y
    Lung Cancer; 2013 Jan; 79(1):77-82. PubMed ID: 23127337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients.
    Cappuzzo F; Tallini G; Finocchiaro G; Wilson RS; Ligorio C; Giordano L; Toschi L; Incarbone M; Cavina R; Terracciano L; Roncalli M; Alloisio M; Varella-Garcia M; Franklin WA; Santoro A
    Ann Oncol; 2010 Mar; 21(3):562-567. PubMed ID: 19767315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.